🇺🇸 FDA

Company profile · Sponsor

Peking

Peking University People's Hospital

CAF09C3 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Peking (CAF09C3) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CAF09C3
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. Furmonertinib

    Peking

    Adenocarcinoma of Lung

    phase 2 small molecule active

    1 trial

  2. Tofacitinib

    Peking

    Primary Sjögren's Syndrome

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Peking?

Peking (CAF09C3) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Peking sponsor?

We track 2 ClinicalTrials.gov-linked programs for Peking, including Furmonertinib and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Peking company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.